News & Policy

The trend of unproven peptides is spreading through influencers and allies

FDA green list

Fat Science Podcast doing the Lords work of scaring people away from Compounded meds

A "gift" from China. A living GLP-1?

Rusfertide For TRT

Novo Nordisk sues Eli Lilly for false advertising

Confessions of a beginner

Tesa out the game? CBL-514 the new Tesa

Eli Lilly to offer early access to Retatrutide to some patients

FDA compounding approvals!!

'The Downsized' has latest Survodutide news.

Forum member returns after seven-day ban with cat stories and banter

Recreational substances and retatrutide

How do we feel about waist to hip ratios?

Quick end to my Cagri trial.

Question about doctors

Another reason not to trust the FDA

Endo-205 anywhere?

Legal issues

Study: Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide?

Telehealth vs Gray Market Access for Weight Loss Medication Experiences and Risks

Name Brand v Compound/Telehealth v Gray

Phase 1 study for Eloralintide and Terzepitide

Major firm halts muscle-sparing obesity drug trial over business concerns, others follow suit

Reduced Cancer Risk With GLP1 Use

Compassionate access to retatrutide and reports of heart-rate changes

Company Offers Ring Sizing Kit Gift

Eloralintide and Tirzepatide Rat Study

Bloomberg article on peptide “Gold Rush”

Investing into Lilly. Thoughts.